AJP - Renal AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (October 19, 2004). doi:10.1152/ajprenal.00436.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/2/F387    most recent
00436.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zheng, J.
Right arrow Articles by Padanilam, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, J.
Right arrow Articles by Padanilam, B. J.
Submitted on December 11, 2003
Accepted on October 15, 2004

POLY (ADP-RIBOSE) POLYMERASE-1 GENE ABLATION PROTECTS MICE FROM ISCHEMIC RENAL INJURY

Jianfeng Zheng1, Kishor Devalaraja-Narashimha1, Kurinji Singaravelu1, and Babu J. Padanilam2*

1 Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, USA
2 Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, USA; Department of Internal Medicine, Section of Nephrology, University of Nebraska Medical Center, Omaha, Nebraska, USA

* To whom correspondence should be addressed. E-mail: bpadanilam{at}unmc.edu.

Increased generation of reactive oxygen species (ROS) and the subsequent DNA damage and excessive activation of poly (ADP-ribose) polymerase-1 (PARP-1) has been implicated in the pathogenesis of ischemic injury. We have previously demonstrated that pharmacological inhibition of PARP protects against ischemic renal injury (IRI) in rats. In order to further define the role of PARP-1 in IRI, we tested whether genetic ablation of PARP-1 attenuates tissue injury after renal ischemia. Twenty- four hours after reperfusion following 37 min of bilateral renal pedicle occlusion, the effects of the injury on renal functions in PARP-/- and PARP+/+ mice were assessed by determining glomerular filtration rate (GFR) and the plasma levels of creatinine. The levels of plasma creatinine were decreased and GFR was augmented in PARP-/- mice. Morphological evaluation of the kidney tissues showed that the extent of damage due to the injury in PARP -/- mice was less compared to their wild type counterparts. The levels of ROS and DNA damage were comparable in the injured kidneys of PARP+/+ and PARP -/- mice. PARP activity was induced in ischemic kidneys of PARP+/+ mice at 6-24 hours postinjury. At 6, 12 and 24 hours after injury, ATP levels in the PARP+/+ mice kidney declined to 28, 26 and 43% respectively while it was preserved close to normal levels in PARP-/- mice. The inflammatory cascade was attenuated in PARP-/- mice as evidenced by decreased neutrophil infiltration and attenuated expression of inflammatory molecules such as TNF-alpha, IL-1 beta and intercellular adhesion molecule-1 (ICAM-1). At 12 hours post- injury, no apoptotic cell death was observed in PARP-/- mice kidneys. However, by 24 hours post-injury, comparable number of cells underwent apoptosis in both PARP-/- and PARP+/+ mice kidneys. Thus, activation of PARP post IRI contributes to cell death most likely by ATP depletion and augmenting the inflammatory cascade in the mouse model. PARP ablation preserved ATP levels, renal functions and attenuated inflammatory response in the setting of IRI in the mouse model. PARP inhibition may have clinical efficacy in preventing the progression of ARF complications.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Devalaraja-Narashimha, A. M. Diener, and B. J. Padanilam
Cyclophilin D gene ablation protects mice from ischemic renal injury
Am J Physiol Renal Physiol, September 1, 2009; 297(3): F749 - F759.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Singaravelu, K. Devalaraja-Narashimha, B. Lastovica, and B. J. Padanilam
PERP, a p53 proapoptotic target, mediates apoptotic cell death in renal ischemia
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F847 - F858.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Devalaraja-Narashimha and B. J. Padanilam
PARP-1 Inhibits Glycolysis in Ischemic Kidneys
J. Am. Soc. Nephrol., January 1, 2009; 20(1): 95 - 103.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. G. Wong, Y. Suzuki, C. Tanifuji, H. Akiba, K. Okumura, T. Sugaya, T. Yamamoto, S. Horikoshi, S. Y. Tan, C. Pollock, et al.
Peritubular Ischemia Contributes More to Tubular Damage than Proteinuria in Immune-Mediated Glomerulonephritis
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 290 - 297.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Devarajan
Update on Mechanisms of Ischemic Acute Kidney Injury
J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1503 - 1520.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
F. Deschenes, L. Massip, C. Garand, and M. Lebel
In vivo misregulation of genes involved in apoptosis, development and oxidative stress in mice lacking both functional Werner syndrome protein and poly(ADP-ribose) polymerase-1
Hum. Mol. Genet., November 1, 2005; 14(21): 3293 - 3308.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. S.A. Patel, U. Cortes, R. Di Poala, E. Mazzon, H. Mota-Filipe, S. Cuzzocrea, Z.-Q. Wang, and C. Thiemermann
Mice Lacking the 110-kD Isoform of Poly(ADP-Ribose) Glycohydrolase Are Protected against Renal Ischemia/Reperfusion Injury
J. Am. Soc. Nephrol., March 1, 2005; 16(3): 712 - 719.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.